Phosphorylation and functionality of CdtR in Clostridium difficile

por Bilverstone, T.W., Minton, N.P., Kuehne, S.A.
Publicado 2019

Development of Clostridium difficile R20291ΔPaLoc model strains and in vitro methodologies reveals CdtR is required for the production of CDT to cytotoxic levels

por Bilverstone, T.W., Kinsmore, N.L., Minton, N.P., Kuehne, S.A.
Publicado 2017

A Novel Bacteriophage with Broad Host Range against Clostridioides difficile Ribotype 078 Supports SlpA as the Likely Phage Receptor

por Whittle, M. J., Bilverstone, T. W., van Esveld, R. J., Lücke, A. C., Lister, M. M., Kuehne, S. A., Minton, N. P.
Publicado 2022

Modifying an immunogenic epitope on a therapeutic protein: a step towards an improved system for antibody-directed enzyme prodrug therapy (ADEPT)

por Mayer, A, Sharma, S K, Tolner, B, Minton, N P, Purdy, D, Amlot, P, Tharakan, G, Begent, R H J, Chester, K A
Publicado 2004

Repeated cycles of Clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivo

por Theys, J, Pennington, O, Dubois, L, Anlezark, G, Vaughan, T, Mengesha, A, Landuyt, W, Anné, J, Burke, P J, Dûrre, P, Wouters, B G, Minton, N P, Lambin, P
Publicado 2006